Search For "intas"
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing a
Updated : 1 month ago IST
Piscataway (New Jersey) [US], February 11: Kashiv BioSciences, LLC ("Kashiv") a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals Ltd ("Intas"), a leading multinational pharmaceutic
Read More
North Gujarat drives 12% of State's pharmaceutical output, eyes global exp
Updated : 5 months, 1 week ago IST
Gujarat is contributing to India's pharmaceutical sector's growth, anchored by supportive government initiatives and investment opportunities. It is home to global companies such as Sun Pharma, Zydus Cadila, Intas Pharmaceuticals, Amneal Pharmaceuticals, and many more.
Read More
Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Globa
Updated : 7 months, 1 week ago IST
Ahmedabad (Gujarat) [India], August 7: Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's leading suppliers of pegfilgrastim following the successful acquisition of UDENYCA® (pegfilgrast
Read More
Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India's Fi
Updated : 7 months, 1 week ago IST
Ahmedabad (Gujarat) [India], August 6: Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC), in the Indian market. This marks another major milestone, following the
Read More
Accord Healthcare receives positive CHMP opinion for IMULDOSA®, ustek
Updated : 1 year, 4 months ago IST
Ahmedabad (Gujarat) [India], October 19: Accord Healthcare Limited (Accord) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorisation for Imuldosa® (development cod
Read More
FDA Approves IMULDOSA® (ustekinumab-srlf), Accord BioPharma's Biosimi
Updated : 1 year, 5 months ago IST
Ahmedabad (Gujarat) [India], October 14: Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that the U.S. Food and Drug Administration (FDA) has approved IMULDOSA (uste
Read More
Intas and Henlius receive positive CHMP opinion for HETRONIFLY® (HANS
Updated : 1 year, 5 months ago IST
Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of HETRONIFLY® (serplulimab, approve
Read More
Intas Pharmaceuticals Ltd. Announces Licensing Agreement with mAbxience fo
Updated : 2 years, 2 months ago IST
Ahmedabad (Gujarat) [India], December 20: Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for a biosimilar
Read More
Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], October 28: Intas Pharmaceuticals Limited ("Intas") has entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. (2696.HK) for the development and commercialisation of serplulimab for Europe and India markets.
Read More
European Medicine Agency accepts Intas' Marketing Authorization Applicatio
Updated : 2 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 14: Intas Pharmaceuticals Ltd. announced that the European Medicine Agency (EMA) confirms acceptance of the Marketing Authorization Application (MAA) for DMB-3115, a biosimilar of Stelara® (Ustekinumab). The MAA has been submitted by Accord Healthcare,
Read More
Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Con
Updated : 2 years, 8 months ago IST
Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS - a DCGI-approved, Tofacitinib Ointment 2 per cent w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patie
Read More
Intas Pharmaceuticals Ltd. marches into the Guinness World Records
Updated : 3 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 21 (ANI/PRNewswire): Intas Pharmaceuticals Ltd., one of the leading pharmaceutical multinationals, has successfully set a Guinness World Record by creating the World's 'Largest Awareness Ribbon made by Awareness Ribbons' with the help of more than 10,000
Read More